Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

New Procedures for Incoming Passengers starting 27/9/2022

 


Procedures for All Incoming Passengers to Lebanon
 
Privacy Policy
The data on this platform is processed in line with the laws in force in the Lebanese Republic, especially the Law of Electronic Transactions and Personal Data No. 81 of 10/10/2018.

The data is currently hosted on a secure cloud that is ISO27001, NIST 800-53 and GDPR compliant and all security requirements are in place to secure the infrastructure. The data and application hosting will be migrated to a secure national datacenter at a later stage.

Work is done with a company specialized in information protection and security and all security requirements on this platform and all security requirements are based on: OWASP Top 10 web applications security risks, OWASP Top 10 API security and OWASP ASVS best practices were taken into consideration during the development phase. Penetration tests are being conducted on the test environment in order to ensure that no vulnerabilities exist before the live implementation. Ongoing penetration tests and checks are being conducted on the live environment in order to ensure that both environments are secured.

We ensure to maintain the confidentiality of your information and provide physical, electronic and procedural safeguards to ensure the protection of the information we process and keep on a secure server. Your data is shared with the laboratory to input the result of the PCR test result done at the airport and the result is sent to your phone via an SMS.

The information you disclosed, such as your name, your father's name, first name, date of birth and place of residence, is encrypted and stored in a secure manner and cannot be accessed by the public, and you have the right to view, correct, modify or delete your data from the database.

We will use your personal information if you are infected with the Coronavirus and you were tested positive for COVID-19 or have been in contact with a positive case, to contact you and give you the necessary directions. Your data will be shared with the Ministry of Interior and Municipalities in order to take preventive measures such as isolation or to do a PCR test to limit the spread of the virus.

Storing this data aims to confront a global epidemic, to contribute to limiting the spread of the Covid-19 epidemic, and to preserve the public health in the Lebanese Republic.


The Privacy Policy
 
MOPH PASS Refund 
Refund Policy:
If you registered on the
https://pass.moph.gov.lb  platform and paid the cost of the PCR test via credit card or via the electronic document EMD and decided not to travel to Lebanon or postpone the travel, you can submit a request for a refund in writing to PASS@MOPH.GOV.LB  within a month of registering on the platform.
All refund requests will be reviewed and evaluated based on the payment status and arrival in Lebanon before a decision is made.
The Ministry reserves the right to refuse a refund based on the data registered in the platform.

MOPH PASS Refund Request
 
Memos and Decisions
 
 




    2
ATC Name B/G Ingredients Dosage Form Price
A02BC05 NEXIUM B Esomeprazole (magnesium trihydrate) - 40mg 40mg Tablet, enteric coated 1,138,235 L.L
A02BC05 NEXPRAZOL 20 G Esomeprazole - 20mg 20mg Tablet, enteric coated 275,168 L.L
A02BC05 NEXIUM B Esomeprazole sodium - 40mg 40mg Injectable powder for solution 5,254,424 L.L
G02BA NUVARING B Etonogestrel - 0.12mg/day, Ethinylestradiol - 0.015mg/day Ring 1,052,229 L.L
C10AB05 NANOFIB G Fenofibrate - 145mg 145mg Tablet, film coated 1,371,615 L.L
L03AA02 NEUPOGEN BioTech Filgrastim - 300mcg/0.5ml 300mcg/0.5ml Injectable solution 5,250,393 L.L
L03AA02 NEOGRASTIM 30 BioTech Filgrastim - 300mcg/ml 300mcg/ml Injectable solution 1,970,969 L.L
L03AA02 NEUTROMAX BioTech Filgrastim - 300mcg/ml 300mcg/ml Injectable solution 2,553,301 L.L
L03AA02 NIVESTIM BioTech Filgrastim - 30MIU/0.5ml 30MIU/0.5ml Injectable solution 17,110,745 L.L
N06AB03 NEANXETIN G Fluoxetine (HCl) - 20mg 20mg Capsule 422,351 L.L
N03AX12 NEUROPLEX G Gabapentin - 300mg 300mg Capsule 1,107,326 L.L
N03AX12 NEUROPLEX G Gabapentin - 400mg 400mg Capsule 1,290,089 L.L
C01DA02 NITRODERM TTS 5 B Glyceryl trinitrate - 5mg/24h 5mg/24h Patch 654,183 L.L
M01AE01 NORFEN 400 G Ibuprofen - 400mg 400mg Tablet, film coated 173,356 L.L
A10AB05 NOVORAPID FLEXPEN BioTech Insulin aspart - 100IU/ml 100IU/ml Injectable solution 3,123,090 L.L
A10AB05 NOVORAPID FLEXPEN BioTech Insulin aspart - 100IU/ml 100IU/ml Injectable solution 3,123,090 L.L
A10AB05 NOVORAPID FLEXPEN BioTech Insulin aspart - 100IU/ml 100IU/ml Injectable solution 3,123,090 L.L
A10AD05 NOVOMIX 30 BioTech Insulin aspart - 30%, Insulin aspart protamine - 70% 100IU/ml Injectable suspension 4,264,012 L.L
A10AD05 NOVOMIX 30 BioTech Insulin aspart - 30%, Insulin aspart protamine - 70% 100IU/ml Injectable suspension 4,264,012 L.L
A10AD05 NOVOMIX 30 BioTech Insulin aspart - 30%, Insulin aspart protamine - 70% 100IU/ml Injectable suspension 4,264,012 L.L
L01XG03 NINLARO B Ixazomib - 2.3mg 2.3mg Capsule, hard 272,619,919 L.L
L01XG03 NINLARO B Ixazomib - 3mg 3mg Capsule, hard 348,420,676 L.L
L01XG03 NINLARO B Ixazomib - 4mg 4mg Capsule, hard 388,991,058 L.L
H02AB04 NEPHARED G Methylprednisolone sodium succinate - 125mg 125mg Injectable powder for solution 469,001 L.L
H02AB04 NEPHARED G Methylprednisolone sodium succinate - 40mg 40mg Injectable powder for solution 188,138 L.L
R01AD09 NASONEX B Mometasone furoate (monohydrate) - 50mcg/dose 0.05% Spray, suspension 529,474 L.L
D10AF05 NADIXA G Nadifloxacin - 1% 1% Cream 850,652 L.L
D10AF05 NAXIDERM G Nadifloxacin - 1% 1% Gel 826,783 L.L
C04AX21 NAFTIPRAX B Naftidrofuryl hydrogen oxalate - 200mg 200mg Tablet, film coated 614,328 L.L
C04AX21 NAFTILUX B Naftidrofuryl oxalate acid - 200mg 200mg Capsule 432,717 L.L
    2
Sitemap
© Copyrights reserved to Ministry of Public Health 2025